Michael Tollini

Mike’s practice includes a broad range of debt finance and capital markets transactions, including acquisition and leveraged finance, private credit, structured finance (including royalty-based financings), debt capital markets (including high yield, convertible and investment grade bonds) and debt restructurings. With over two decades of experience, Mike is consistently recognized by Chambers USA, The Legal 500 and Super Lawyers for his market leadership in both secured lending and debt capital markets. Mike is noted for his expertise on both the sponsor/borrower side and the bank side, and for his execution of high-profile transactions across a range of industries including life sciences, technology, healthcare, fintech and telecommunications.  

A selection of Mike's matters includes:

Credit Facilities Provided to Public Companies

• Reata Pharmaceuticals
• Immunocore
• Tenable
• Horizon Therapeutics
• Jazz Pharmaceuticals
• Uber
• The Honest Company
• BioMarin Pharmaceutical
• NETSTREIT
• Malibu Boats
• BioTE Medical
• Air Lease
• Madrigal Pharmaceuticals
• Lucira Health
• Casper Sleep
• Apollo Endosurgery
• Biohaven
• Meredith
• TiVo

Credit Facilities Provided to Private Equity Portfolio Companies, Other Private Companies

• Representation of portfolio company borrowers affiliated with private equity firms such as Battery Ventures, Clarion Capital, Clearlake Capital, General Catalyst, Pamplona Capital, Razor’s Edge and General Atlantic
• Representation of venture capital-backed private company borrowers ranging from early stage to late stage “unicorns” in connection with a variety of term loan and/or revolving (including asset-based) credit facilities provided by commercial and investment banks, including JPMorgan, Bank of America, PNC Bank, Silicon Valley Bank, Truist, Goldman Sachs, Canadian Imperial Bank of Commerce (CIBC), Morgan Stanley and Capital One
• Representation of life sciences and technology borrowers (including in connection with structured and/or royalty-based financings) provided by CRG, Hercules, Sixth Street, Pharmakon, Deerfield, Ares, Vista Credit Partners, Healthcare Royalty Partners (HCR), Royalty Pharma, HPS Partners (formerly Highbridge), SLR (formerly Solar Capital), Goldman Sachs Asset Management (GSAM), TriplePoint Capital, Innovatus and Oberland
• Representation of financing sources such as Midcap Financial, Western Alliance Bank, Wells Fargo, First Republic Bank, Broad Oak, City National Bank and Silicon Valley Bank

Debt Capital Markets

• Horizon Therapeutics
• Nvidia
• Twilio
• Meredith
• Uber
• J2 Global*
• Western Global Airlines
• Zoetis
• The Clorox Company*

*indicates underwriter representation

Structured Life Science Transactions

• Reata Pharmaceuticals
• Paratek Pharmaceuticals
• Clearside Biomedical
• Mirum Pharmaceuticals
• Biohaven
• Dermavant Sciences